Clinical Trials Insight: 700059334

Trial Profile

Clinical Trials Insight: 700059334

Phase of Trial: Phase I

Latest Information Update: 25 Feb 2011

At a glance

  • Drugs Exenatide; Glucagon-like peptide 1 agonist
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 25 Feb 2011 Status changed from recruiting to completed.
    • 23 Feb 2011 Positive pharmacokinetic results released by TransPharma Medical, showing an extended pharmacokinetic profile with transdermal glucagon-like peptide-1 agonist, compared with exenatide.
    • 16 Sep 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top